A Randomized, Open Label, Multiple Dose, Cross-over, Phase I Trial to Evaluate a Pharmacokinetic Drug Interaction and Safety Between Valsartan and Rosuvastatin in Healthy Male Volunteers

Trial Profile

A Randomized, Open Label, Multiple Dose, Cross-over, Phase I Trial to Evaluate a Pharmacokinetic Drug Interaction and Safety Between Valsartan and Rosuvastatin in Healthy Male Volunteers

Completed
Phase of Trial: Phase I

Latest Information Update: 20 Jun 2014

At a glance

  • Drugs Rosuvastatin (Primary) ; Rosuvastatin/valsartan (Primary) ; Valsartan (Primary)
  • Indications Atherosclerosis; Cardiovascular disorders; Heart failure; Hypercholesterolaemia; Hyperlipidaemia; Hypertension; Hypertriglyceridaemia; Myocardial infarction
  • Focus Therapeutic Use
  • Sponsors LG Life Sciences
  • Most Recent Events

    • 13 Aug 2013 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top